Epilepsy drives autism in neurodevelopmental disorders

Developmental Medicine and Child Neurology

Volumn 55, Issue 2, 2013, Pages 101-102

  Hagerman, Randi J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; ARBACLOFEN; FRAGILE X MENTAL RETARDATION PROTEIN; GELATINASE B; GLUTAMIC ACID; METHYL CPG BINDING PROTEIN 2; MINOCYCLINE; TUBERIN;

AUTISM; EPILEPSY; FRAGILE X SYNDROME; GENE EXPRESSION; GENE MUTATION; HUMAN; NERVE CELL NETWORK; NEUROFIBROMATOSIS; NEUROLOGIC DISEASE; NOTE; PRIORITY JOURNAL; SEIZURE;

AUTISTIC DISORDER; EPILEPSY; FEMALE; HUMANS; INTELLIGENCE; MALE; SOCIAL ADJUSTMENT;

EID: 84872565522     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12071     Document Type: Note

References (13)

1. van Eeghen AM, Pulsifer MB, Merker VL, et al. Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach. Dev Med Child Neurol 2013; 55: 146-53.
2. Iossifov I, Ronemus M, Levy D, et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012; 74: 285-99.
3. Chen Y, Tassone F, Berman RF, et al. Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum Mol Genet 2010; 19: 196-208.
4. Chonchaiya W, Au J, Schneider A, et al. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Hum Genet 2012; 131: 581-9.
5. Berry-Kravis E, Raspa M, Loggin-Hester L, et al. Seizures in fragile X syndrome: characteristics and comorbid diagnoses. Am J Intellect Dev Disabil 2010; 115: 461-72.
6. Qureshi IA, Mehler MF. Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiol Dis 2010; 39: 53-60.
7. Wilczynski GM, Konopacki FA, Wilczek E, et al. Important role of matrix metalloproteinase 9 in epileptogenesis. J Cell Biol 2008; 180: 1021-35.
8. Bernard P, Castano A, Benke T. Disruption of FMRP-p70 S6 kinase-PP2A complex by early life seizures underlies enhanced mLTD in adult rats. Poster presented at the Forty-Second Annual Meeting of the Society for Neuroscience, New Orleans, LA, USA, 13-17 October 2012.
9. Bilousova TV, Dansie L, Ngo M, et al. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet 2009; 46: 94-102.
10. Paribello C, Tao L, Folino A, et al. Open-label add-on treatment trial of minocycline in fragile X syndrome. BMC Neurol 2010; 10: 91.
11. Jacquemont S, Curie A, Des Portes V, et al. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med 2011; 3: 64ra1.
12. Berry-Kravis EM, Hessl D, Rathmell B, et al. Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial. Sci Transl Med 2012; 4: 152ra127.
13. Fatemi SH, Folsom TD. The role of fragile X mental retardation protein in major mental disorders. Neuropharmacology 2011; 60: 1221-6.